Current Paths

Publicly reported work relevant to writing information into the visual cortex, and the high-bandwidth interfaces that make it plausible. Status as of late 2026.

Visual Cortex Stimulation

Neuralink — Blindsight

Aims to stimulate the visual cortex directly to produce phosphenes, bypassing the eyes and optic nerve. Received FDA Breakthrough Device Designation in 2024. In October 2026, Elon Musk stated the device was engineering-ready and awaiting regulatory approval. No published human visual results have been released. Early resolution has been described as low.

High-Bandwidth Platform

Neuralink — N1 / Telepathy

Wireless intracortical implant using flexible threads. Human trials are ongoing. Public reports cited roughly 21 participants by early 2026, with work on cursor control and speech. This is the underlying platform technology that a visual interface would build on.

Surface Approaches

Precision Neuroscience — Layer 7

Thin-film array placed on the cortical surface. Holds FDA clearance for temporary use up to 30 days. High electrode density per module. Currently oriented more toward mapping and short-term research than permanent visual interfaces.

Lower-Invasiveness Paths

Synchron and others

Endovascular and other reduced-invasiveness approaches exist, primarily focused on motor control today. They demonstrate that neural interfaces can reach humans with different surgical burdens, but currently offer lower bandwidth than intracortical systems.

This page tracks publicly reported milestones. It does not claim that any device is commercially available or proven for general visual interface use.